Meqsel 2mg Tablet 30s

Introduction to Meqsel 2mg Tablet 30s

Meqsel 2mg Tablet 30s is a medication primarily used to treat certain types of cancer, such as melanoma with a BRAF V600E or V600K mutation. This tablet form of medicine is designed to target specific changes in cancer cells that promote their growth.

Composition of Meqsel 2mg Tablet 30s

Meqsel 2mg Tablet 30s contains the active ingredient Trametinib, which functions by inhibiting a protein called MEK involved in cell growth and division. This action helps slow down or stop the proliferation of cancer cells.

Uses of Meqsel 2mg Tablet 30s

• Treatment of melanoma with BRAF V600E or V600K mutation

Side effects of Meqsel 2mg Tablet 30s

• Common side effects: rash, diarrhea, fatigue
• Serious side effects: heart problems including heart failure, retinal detachment

Precautions of Meqsel 2mg Tablet 30s

Meqsel 2mg Tablet 30s may cause heart-related issues, including heart failure, and eye problems such as retinal detachment. It is important to monitor for these conditions and consult a healthcare provider if symptoms arise.

How to Take Meqsel 2mg Tablet 30s

The usual starting dose of Meqsel 2mg Tablet 30s for adults is 2 mg once daily. It should be taken on an empty stomach, either 1 hour before or 2 hours after a meal. Always follow your doctor's instructions regarding dosage and administration.

Conclusion of Meqsel 2mg Tablet 30s

Meqsel 2mg Tablet 30s, containing the active ingredient Trametinib, is part of the therapeutic class of cancer treatments targeting specific mutations. It is manufactured to address melanoma with BRAF V600E or V600K mutations. Key highlights include its targeted action on cancer cell growth and the importance of monitoring for potential side effects. Meqsel 2mg Tablet 30s is a crucial option for patients with specific cancer mutations, offering a targeted approach to treatment.